Synthes’ deal with Kensey Nash seems OK with feds (Philly.com)
Without saying they approve or disapprove of such deals, the federal officials supervising the Synthes Inc. divestiture of its Norian subsidiary’s assets have indicated – sort of – that Tuesday’s $22 million sale to Exton-based Kensey Nash is acceptable.
Synthes, the medical-device manufacturer near West Chester, had to shed its Norian assets as part of a plea bargain to settle criminal charges that it ran an illegal test market of the subsidiary’s bone cement from 2002 to 2004.